🟢 Mirum Pharmaceuticals is trading 4.1% up today after conference presentations highlighted strong LIVMARLI sales

Mirum Pharmaceuticals is trading 4.1% up now at $97.77, following investor presentations at the H.C. Wainwright conference on September 15 and a scheduled Morgan Stanley healthcare conference fireside chat on September 16, where management highlighted strong LIVMARLI sales and multiple upcoming clinical and regulatory milestones.

• The move is notable as broader biotech sentiment remains weak while Mirum advances.
• No separate September 16 regulatory approval, earnings release, or major transaction was identified; the conference-driven catalyst appears most likely.